iZafe Group invites shareholders and others to a Q&A session following the publishing of the second quarter report

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its second quarter report. The report will be available to the public on August 4, 2021 at 08:30 (8:30 a.m.) CET.

Questions will be answered by Chief Executive Officer Anders Segerström and published on August 6, 2021 on iZafe Group's investor site under the heading Financial Reports, Investor Questions.

Please send your questions tobefore 10:00 (10 a.m.) CET on August 5, 2021.

About Us

iZafe Group is a Swedish med-tech company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafegroup.com/investor-relations.

iZafe Group invites shareholders and others to a Q&A session following the publishing of the second quarter report